Mit Magzter GOLD unbegrenztes Potenzial nutzen

Erhalten Sie unbegrenzten Zugriff auf über 9.000 Zeitschriften, Zeitungen und Premium-Artikel für nur

$149.99

$74.99/Jahr

Versuchen GOLD - Frei

Mit Magzter GOLD unbegrenztes Potenzial nutzen

Erhalten Sie unbegrenzten Zugriff auf über 9.000 Zeitschriften, Zeitungen und Premium-Artikel für nur

$NaN

$NaN/Jahr

Beeilen Sie sich, das Angebot ist zeitlich begrenzt!

Std

Minuten

Sekunden

Chronicle Pharmabiz - January 15, 2026

Mit Magzter GOLD unbegrenztes Potenzial nutzen

Lesen Chronicle Pharmabiz zusammen mit über 9.000 anderen Zeitschriften und Zeitungen mit nur einem Abonnement

Katalog anzeigen

1 Monat

$14.99

1 Jahr $149.99

$74.99

$6/month

Save 50%
Hurry, Offer Ends in 10 Days

(OR)

Abonnieren Sie nur Chronicle Pharmabiz

Geschenk Chronicle Pharmabiz

Jederzeit kündbar.

(Keine Verpflichtungen) ⓘ

Sollten Sie mit Ihrem Abonnement nicht zufrieden sein, senden Sie uns innerhalb von 7 Tagen nach Abonnementbeginn eine E-Mail an help@magzter.com, um eine vollständige Rückerstattung zu erhalten. Versprochen! (Hinweis: Gilt nicht für den Kauf einzelner Ausgaben.)

Digitales Abonnement

Sofortiger Zugriff ⓘ

Abonnieren Sie jetzt, um sofort mit dem Lesen auf der Magzter-Website sowie in den iOS-, Android- und Amazon-Apps zu beginnen.

Verifiziert sicher

zahlen ⓘ

Magzter ist ein verifizierter Authorize.Net-Händler. Weitere Informationen

In dieser Ausgabe

Volume 26, Issue No. 8 - January 15, 2026
Chronicle Pharmabiz

DoP calls for proposals to set up common facilities for device clusters

THE Department of Pharmaceuticals (DOP) has invited applications from eligible stakeholders to set up common facilities for medical device clusters in the country, under the scheme for Strengthening of Medical Device Industry (SMDI).

2 mins

Govt may exempt 11 drugs from procurement rules

THE Department of Pharmaceuticals (DoP) has proposed to add 11 more drugs including insulin and monoclonal antibodies to the list of 84 drug formulations it has mentioned in November, 2025, to be exempted from Global Tender Enquiry (GTE), under the General Financial Rules, 2017, for tenders up to Rs. 200 crore.

1 mins

Practo launches care navigation platform in US

PRACTO, one of the world's most trusted digital healthcare platforms, announced the launch of its care navigation platform in the United States, marking its most significant international expansion following a strong debut in the UAE in the year 2025.

1 mins

India's vision health signals shift with innovation in cataract surgery

INDIA's eye care landscape is witnessing a significant paradigm shift driven by precision innovations in cataract surgery and the advent of specialized defocus lenses for myopia management.

2 mins

Need to develop certification for wellness centres: Experts

THERE is a need to develop certification standards for wellness centres aligned with global standards to position India as a premier wellness destination, according to experts.

1 mins

Indian pharma eyes prospects with needle-free drug delivery

NEEDLE-free drug delivery is moving from a promising innovation to an expected standard. As patients look for comfort, ease of use, and more control over their treatments, the appetite for needle-free options has surged.

1 mins

BioAsia 2026 to be held from Feb 16 to 18 in Hyderabad

BIOASIA 2026, the 23rd edition of Asia’s premier life sciences and health-technology forum, was released by Telangana minister for IT, electronics & communications, and industries & commerce, D Sridhar Babu.

1 mins

Bulk drugs, intermediates imports decline 2.8% in Nov

IMPORTS of bulk drugs and intermediates to India registered a decline of 2.81% in the month of November, 2025, while exports grew 11% during the month as compared to the same period of previous year.

1 mins

Comm Min launches MAS under EPM-NIRYAT DISHA to boost exports

THE Union ministry of commerce has launched Market Access Support (MAS) intervention under the Export Promotion Mission (EPM)-NIRYAT DISHA with immediate effect towards strengthening India's export market access.

2 mins

DGFT amends norms for exporting metformin HCL

Our Bureau, Mumbai HE Directorate General of Foreign Trade (DGFT) has notified amendments in measurement for key inputs or import items under standard input output norms (SION) A-290 for exporting active pharmaceutical ingredient (API) metformin hydrochloride (HCL).

1 mins

Pharmexcil leads delegation to CIS region to explore biz opportunities

IN order to tap the emerging business opportunities in Commonwealth of Independent States (CIS), Pharmaceuticals Export Promotion Council of India (Pharmexcil) with the support of the Ministry of Commerce and Industry is organizing IPHEX-CIS (Business Delegation to Belarus, Russia, Uzbekistan & Kazakhstan) between March 16 and 28, 2026.

2 mins

India bolsters medical transportation with technology

INDIA is strengthening its medical transportation system for chronic care patients through strategic integration of technology. With advanced tracking systems, telemedicine support, and real-time route optimization, hospitals and healthcare providers are working to ensure safer, faster, and more reliable patient travel. This technology-driven approach aims to reduce delays, improve coordination, and enhance the overall quality of care for patients who require frequent medical attention.

1 mins

MTaI seeks govt to align med-tech customs, GST structures

THE Medical Technology Association of India (May), the sociation of India (MTal), the association of research-based medical technology companies with global experience in innovation and manufacturing in India, has said that the Central government should align the medtech customs and Goods and Services Tax (GST) structures with other priority sectors to support domestic manufacturing of medical devices.

1 mins

AiMeD asks govt to hike import tariffs from 7.5% to 10-15% to boost domestic mfg

THE Association of Indian Medical Device Industry (AiMeD) has urged the Central Government to consider raising import tariffs to 10 to 15 per cent from the current 7.5 per cent, adopt quality-based criteria in public procurement with preference for Indian Certification for Medical Devices (ICMED) certification over foreign approvals, and updating labelling norms to disclose domestic content percentage and incentivise local value addition, in the upcoming Union Budget 2026-27.

2 mins

DCGI releases classification of 77 medical devices related to oncology

As part of its efforts to regulate the medical devices in the country, the Drugs Controller General (India) has issued a notice classifying 77 medical devices pertaining to oncology under the provisions of Medical Devices Rules (MDR), 2017.

2 mins

India needs review of labelling requirements for medicines

INDIA needs a comprehensive review of labelling requirements for drugs, foods, and Ayush medicines to ensure clarity, consistency, and consumer safety across regulated products, said D B Anantha Narayana, CSO, Ayurvidye Trust.

2 mins

How technology advancements can help alleviate myopia rise

MYOPIA is a widespread vision issue affecting over two billion individuals across the globe and it at present growing public health challenge. With an estimated 161 million people experiencing blindness or moderate-to-severe vision loss from uncorrected refractive errors in 2020 and it has become a leading cause of vision impairment.

3 mins

Utilise Their Expertise

THE MIT Pharmacy College in Mysuru has recently urged the Union Health Ministry to include Pharm D (Doctor of Pharmacy) graduates in the eligibility criteria for the post of Drug Inspectors and Food Inspectors. In July 2019, the Union Health Ministry had issued a gazette notification clearly stating that a person holding the Pharm D qualification, being a higher qualification, shall automatically become eligible for appointment to various posts where a person holding Diploma in Pharmacy or Bachelor of Pharmacy or Master of Pharmacy qualification is eligible to be appointed. Further, as Pharm D is an approved qualification under the Pharmacy Act, 1948, the Pharmacy Council of India has continuously been requesting the Central and State governments to amend recruitment rules to include Pharm D for various posts. More importantly, the Drugs Technical Advisory Board (DTAB), the highest authority under the Union Health Ministry on technical matters, has reportedly agreed to amend the Drugs & Cosmetics Rules, 1945, to explicitly include Pharm D for the qualifications of inspectors. But, the fact remains that there is still inconsistent application of the Pharm D qualification for key public health posts across the country, specifically the Drug Inspectors and Food Inspectors roles. It is deplorable that even though Pharm D is a higher and more extensive qualification than B Pharm and M Pharm, its automatic eligibility is frequently disregarded by various recruiting agencies in the country including Union Public Service Commission and State Public Service Commissions.

1 mins

Pondicherry DC mandates 100% batch testing to combat counterfeit drugs

FOLLOWING the recent exposure of a massive multi-state counterfeit medicine racket that has been referred to the CBI and NIA, the Pondicherry Department of Drugs Control has launched an aggressive regulatory cleansing of the pharmaceutical sector to restore public trust and safety.

1 mins

'CDSCO's labelling reforms a constructive step for globally aligned ecosystem'

INDIAN pharmaceutical companies have taken note of the CDSCO recent labelling reforms, viewing them as a constructive step toward building a more globally aligned pharmaceutical ecosystem.

1 mins

DCA Telangana raids illegal clinic in Hanumakonda

THE Drugs Control Administration (DCA) of Telangana conducted a targeted raid on an illegal clinic in Dameral Village at Elkathurthi Mandal in Hanumakonda District, on Tuesday, January 6.

1 mins

Telangana DCA seizes illegal drugs from practitioner

THE Drugs Control Administration (DCA) of Telangana conducted a strategic raid targeting an illegal medical practice in Vidya Nagar in Karimnagar.

1 mins

Experts recommend ending inverted duty structure in Budget

EXPERTS have recommended eliminating inverted duty structure, incentives for research, health-tech startups among others in Union Budget 2026.

2 mins

Haryana FDA cracks down overpricing, 33 violations in 2025

IN a significant move to protect consumer interests, the Haryana FDA has reported a major crackdown on drug overpricing across the state.

2 mins

DCA's report highlights expansion of enforcement, global regulatory

THE 2025 annual report of actions initiated by the Telangana Drug Control Administration (DCA) states that the department placed the highest priority on curbing the illegal circulation of habit-forming drugs.

2 mins

'Separate licensing for bulk drugs to plug regulatory gap in supply'

THE Union health ministry's proposal to revamp work for bulk drugs, active pharmaceutical ingredients (APIs) and key starting materials (KSMs) will plug regulatory gap in the supply chain, according to Harish Jain, national president, Federation of Pharma Entrepreneurs (FOPE).

2 mins

AHPI calls for adoption of 'CIBIL-like' framework

THE West UP Chapter of the Association of Healthcare Providers India (AHPI) has called for the establishment of a 'CIBIL-like' rating framework for insurers and Third Party Administrators (TPAs) to bring transparency and accountability in the healthcare sector.

1 mins

IPC's relaunch of toll-free helpline as a multilingual IVRS to improve ADRs

THE Indian Pharmacopoeia Commission (IPC)'s re-launch of its toll-free helpline (1800-180-3024) as an advanced multilingual Interactive Voice Response System (IVRS), through the Pharmacovigilance Programme of India (PVPI), has been designed to improve medicine related adverse drug reaction (ADR) reporting and enhance patient safety, according to officials associated with the development.

1 mins

India crosses milestone of 50,000 NQAS certifications

THE Government of India has announced that a total of 50,373 public health facilities across all states and Union Territories in the country have been certified under the National Quality Assurance Standards (NQAS) - a comprehensive quality framework established by the ministry of health and family welfare (MoHFW) - as on December 31, 2025.

1 mins

Yoga can speed up recovery from opioid withdrawal symptoms: Study

THE National Institute of Mental Health and Neuro Sciences (NIMHANS) Centre for Addiction Medicine has found that Yoga can dramatically speed up recovery from opioid withdrawal symptoms by cutting recovery time nearly by half.

2 mins

Allegations of electoral fraud, malpractice in APPC election

THE Andhra Pradesh Pharmacy Council (APPC) election, conducted in December 2025, has now become a major legal and administrative crisis following an emergency complaint filed with the state's chief secretary.

1 mins

BDCDA seeks reconsideration of K'taka D&C Rules amendments

THE Bangalore District Chemists and Druggists Association (BDCDA) has called for reconsideration and appropriate inclusion of certain rules in the amendments to Rules under the Drugs and Cosmetics Act (Karnataka Amendment) Act, 2025. This bill was presented in December 2025 at Legislature session at Belagavi by Karnataka health & family welfare minister, Dinesh Gundu Rao.

2 mins

'India falls short of global norms in pharmacist-supervised OTC drug dispensing'

INDIA falls short of global norms for pharmacist-supervised OTC (over the counter) drug dispensing, as these medicines are frequently sold without the involvement of a qualified, registered pharmacist. In many developed and emerging healthcare systems, pharmacist supervision is a regulatory requirement to ensure appropriate medicine selection, prevent misuse, manage drug interactions, and enhance patient safety.

1 mins

PAI Pharma acquires Nivagen Pharmaceuticals

PAI Pharma, US-based pharmaceutical manufacturer specializing in oral liquid generic prescription medications with strong domestic manufacturing footprint and a commitment to quality, affordability, and supply chain resilience, and Olympus Partners, a leading US developer, manufacturer and marketer of oral liquid medicines, announced the acquisition of Nivagen Pharmaceuticals, Inc. (Nivagen), a California-based pharmaceutical company with advanced aseptic manufacturing infrastructure and a robust pipeline of ready-to-use sterile injectables.

1 mins

UK MHRA approves Ogsiveo to treat desmoid tumours

THE UK Medicines and Healthcare products Regulatory Agency (MHRA) has on 7th January, 2026 approved the medicine Nirogacestat hydrobromide (Ogsiveo) for the treatment of progressing desmoid tumours in adults.

1 mins

Novartis to build its 4th US radioligand therapy mfg unit in Winter Park

NOVARTIS, a leading global innovative medicines company, announced plans to build its fourth US radioligand therapy (RLT) manufacturing facility in Winter Park, Florida.

1 mins

Dr Reddy's launches recombinant vaccine for HEV prevention

DR Reddy's Laboratories has launched a novel Hevaxin, recombinant vaccine for the prevention of hepatitis E virus (HEV) infection in India. Hevaxin is the only vaccine approved by the Drug Controller General of India (DCGI) for the indication of active immunization against HEV infection in adults aged 18 to 65 years in India.

1 mins

Biocon Biologics unveils 3 biosimilars

BIOCON Biologics, a fully integrated global biosimilars company and subsidiary of Biocon, will introduce three new oncology biosimilars, further strengthening its comprehensive cancer portfolio. The company will also highlight its plans to integrate as a wholly owned subsidiary of Biocon Limited and the vital role of biosimilars in expanding access to affordable medicines at the 44th Annual J P Morgan Healthcare Conference in San Francisco.

1 mins

Medanta launches 'Socho Mat Baat Karo' campaign

MEDANTA, The Medicity, one of India's leading super-speciality hospitals, has launched its community-focused prostate cancer awareness initiative, 'Socho Mat Baat Karo' (SMBK).

2 mins

ACC drives TB detection with portable X-ray

ACC, part of the diversified Adani portfolio and the fastest-growing building materials and solutions company, is supporting India's TB Mukt Bharat Abhiyan through technology-enabled healthcare interventions.

1 mins

Year 2025's concerning dry eye disease to pave way for monitoring in 2026

DRY eye disease became a widespread concern in 2025, fuelled by urban pollution, extended screen time, and air-conditioned environments. Patients reported burning, irritation, and blurred vision, while younger populations reported digital eye strain.

2 mins

Panel asks MoA to intensify efforts to clear pending UCs

RAISING concerns over the insufficient level of liquidation of Utilisation Certificates (UCs) related to the schemes under the Ministry of Ayush, the Parliamentary Panel on Health and Family Welfare has urged the Ministry to intensify efforts to expedite the clearance of pending UCs, particularly under the National Ayush Mission (NAM).

3 mins

India's herbal, Ayurveda prioritize clean labels to strengthen trust

INDIA's herbal and Ayurveda sector is increasingly transparency prioritizing and clean labelling to build consumer trust and reinforce the integrity of its products.

2 mins

'MSMEs need handholding to implement e-submission of WHO-GMP CoPP'

PHARMA MSMEs need assistance to implement Central Drugs Standard Control Organisation (CDSCO)'s mandate of applying online for World Health Organization-Good Manufacturing Practices (WHO-GMP) Certificate of Pharmaceutical Product (CoPP), according to the BDMAI president A P Rameswara Rao.

1 mins

Lesen Sie alle Geschichten von Chronicle Pharmabiz

Chronicle Pharmabiz Description:

Herausgeber: Saffron-Media-Pvt-Ltd

Kategorie: Health

Sprache: English

Frequenz: Weekly

Launched on 21 December 2000, Chronicle Pharmabiz is the No. 1 Pharma news weekly in the South Asian markets; with a target readership that includes 100% coverage of top and middle management pharma professionals across the region.